Jul 31, 2025 | False Claims Act, Fraud Investigations, Government Contract
As we write about regularly, the False Claims Act (FCA) is the government’s most powerful civil fraud-fighting tool, giving the government the ability to conduct sweeping investigations and pursue treble (3x) damages and per-claim penalties. Moreover, the...
Jul 30, 2025 | Uncategorized
The U.S. Food and Drug Administration is moving to restrict 7-hydroxymitragynine (7-OH), a derivative of the kratom plant that is commonly sold online and in vape stores. Citing concerns that 7-OH has opioid-like effects and could be similarly addictive, Health...
Jul 24, 2025 | False Claims Act, federal investigations, Fraud Investigations
In yet another False Claims Act (FCA) settlement involving avoidance of customs duties, on July 23, 2025, the Department of Justice (DOJ) announced that New Hampshire-based Global Plastics and Marco Polo International — both subsidiaries of MGI International...
Jul 22, 2025 | False Claims Act, federal investigations, Fraud Investigations
On July 15, the United States Attorney’s Office for the District of South Carolina announced that it had intervened in a case brought under the False Claims Act (FCA)’s qui tam (whistleblower) provisions. The lawsuit was filed against Global Office...
Jul 17, 2025 | False Claims Act, Fraud Investigations, Government Investigations, Health Care, Health Care Fraud, Medicare and Medicaid
On July 17, 2025, the Department of Justice (DOJ) and the States of Colorado, Georgia, and South Carolina announced that the former CEO and owner of a now-defunct laboratory agreed to a consent judgment of over $27.5 million under the False Claims Act (FCA),...
